{{Rsnum
|rsid=12079081
|Chromosome=1
|position=184284867
|Orientation=plus
|GMAF=0.2553
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 67.3 | 31.0 | 1.8
| HCB | 98.5 | 1.5 | 0.0
| JPT | 84.1 | 11.5 | 4.4
| YRI | 10.9 | 40.1 | 49.0
| ASW | 24.6 | 31.6 | 43.9
| CHB | 98.5 | 1.5 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 66.3 | 32.7 | 1.0
| LWK | 9.1 | 43.6 | 47.3
| MEX | 50.9 | 43.9 | 5.3
| MKK | 23.2 | 42.6 | 34.2
| TSI | 72.5 | 24.5 | 2.9
| HapMapRevision=28
}}

{{Report GE
|PubMed=17876339
|Source=pubmed
|AffyProbeset=SNP_A-1851396
|AffyOrientation=reverse
|AlleleA=C
|AlleleB=T
|onGW5=1
|rsid=12079081
|ancestral=G
|RiskPopulation=
|RiskAllele=G
|CaseFreq=
|ControlFreq=
|OddsRatioHet=1.20
|OddsRatioHom=1.70
|OddsRatioAll=
|Disease=Prostate cancer
|DiseaseSymbol=PC
}}

rs12079081 is in linkage disequilibrium with a polymorphism that increases susceptibility to Prostate cancer 1.20 times for heterozygotes (AG) and 1.70 times for homozygotes (GG) {{PMID|17876339}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}